GlycoMimetics Inc investor relations material

Listen to the latest call from GlycoMimetics Inc

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's primary focus is on developing a pipeline of product candidates in collaboration with The University of Florida and the National Institute of Health.

Upcoming events

Previous events

Dig deeper into the GlycoMimetics Inc fundamentals on Quartr.